Fusion Pharmaceuticals SG&A Expense (Quarterly) Analysis

Fusion Pharmaceuticals Inc (FUSN)

21.45 -0.04 (-0.19%) USD | NASDAQ | May 03, 16:00

21.44 -0.02 (-0.07%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	7.628M
September 30, 2023	6.81M
June 30, 2023	7.753M
March 31, 2023	9.006M
December 31, 2022	6.95M
September 30, 2022	7.42M
June 30, 2022	7.781M
March 31, 2022	8.449M
December 31, 2021	6.336M
September 30, 2021	7.156M

Date	Value
June 30, 2021	6.642M
March 31, 2021	6.964M
December 31, 2020	6.639M
September 30, 2020	5.79M
June 30, 2020	3.988M
March 31, 2020	4.327M
December 31, 2019	2.724M
September 30, 2019	1.922M
June 30, 2019	1.771M
March 31, 2019	1.171M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.771M

Minimum

Jun 2019

9.006M

Maximum

Mar 2023

6.108M

Average

6.81M

Median

Sep 2023

SG&A Expense (Quarterly) Benchmarks